Novel Therapies: How CAR T Cells and Biosimilars Are Changing Cancer Care.

The article focuses on chimeric antigen receptor (CAR) T-cell therapy and biosimilars. It refers to a comment by Oncology Nursing Society (ONS) member Misty Lamprecht regarding the need for nurses to make sure patients understand about CAR T cells. It highlights the U.S. Food and Drug Administration's (FDA) approval of two indications for CAR T-cell therapy.